Literature DB >> 20427706

Endothelin B receptor stimulation inhibits suicidal erythrocyte death.

Michael Föller1, Hasan Mahmud, Syed M Qadri, Shuchen Gu, Manuel Braun, Diwakar Bobbala, Berthold Hocher, Florian Lang.   

Abstract

Endothelins (ETs), potent endothelium-derived mediators, stimulate formation of nitric oxide, which, in turn, protects against suicidal erythrocyte death or eryptosis, characterized by phosphatidylserine exposure at the erythrocyte surface and triggered by increase in cytosolic Ca(2+) ([Ca(2+)](i)). The present study explored whether the ET1-receptor ETB influences suicidal erythrocyte death. To this end, [Ca(2+)](i) (Fluo3-fluorescence) and phosphatidylserine exposure (annexin V-binding) were determined utilizing FACS analysis. Energy depletion increased [Ca(2+)](i) and phosphatidylserine-exposure, effects significantly blunted by ET1 (IC(50) approximately 100 nM) and the ETB receptor-agonist sarafotoxin 6c (IC(50) approximately 10 nM) but not by ET2 and ET3. ET1 and sarafotoxin significantly delayed the kinetics of suicidal erythrocyte death following energy depletion. ETB stimulation did not blunt the effect of Ca(2+)-ionophore ionomycin (1 microM) on phosphatidylserine exposure. The in vivo significance was tested using rescued ETB-knockout (etb(-/-)) and wild-type (etb(+/+)) mice. The number of phosphatidylserine-exposing erythrocytes, of reticulocytes and spleen size were significantly larger in etb(-/-) mice than in etb(+/+)-mice. The etb(-/-) erythrocytes were more susceptible to the eryptotic effect of oxidative stress and more rapidly cleared from circulating blood than etb(+/+) erythrocytes. Finally, the spleens from etb(-/-) mice were enlarged and contained markedly more phosphatidylserine-exposing erythrocytes than spleens from etb(+/+) mice. The observations disclose a novel function of ET1, i.e., protection from suicidal erythrocyte death.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427706     DOI: 10.1096/fj.10-159483

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  8 in total

1.  Physiology and pathophysiology of eryptosis.

Authors:  Florian Lang; Elisabeth Lang; Michael Föller
Journal:  Transfus Med Hemother       Date:  2012-09-06       Impact factor: 3.747

2.  Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3.

Authors:  Emanuela Ferru; Katie Giger; Antonella Pantaleo; Estela Campanella; Jesse Grey; Ken Ritchie; Rosa Vono; Francesco Turrini; Philip S Low
Journal:  Blood       Date:  2011-04-07       Impact factor: 22.113

3.  Reversible binding of hemoglobin to band 3 constitutes the molecular switch that mediates O2 regulation of erythrocyte properties.

Authors:  Haiyan Chu; Mary M McKenna; Nathan A Krump; Suilan Zheng; Laurel Mendelsohn; Swee Lay Thein; Lisa J Garrett; David M Bodine; Philip S Low
Journal:  Blood       Date:  2016-09-29       Impact factor: 22.113

4.  Cardiac-specific knockout and pharmacological inhibition of Endothelin receptor type B lead to cardiac resistance to extreme hypoxia.

Authors:  Tsering Stobdan; Dan Zhou; Alexander T Williams; Pedro Cabrales; Gabriel G Haddad
Journal:  J Mol Med (Berl)       Date:  2018-08-01       Impact factor: 4.599

Review 5.  Macitentan for the treatment of pulmonary arterial hypertension.

Authors:  Cyrus A Kholdani; Wassim H Fares; Terence K Trow
Journal:  Vasc Health Risk Manag       Date:  2014-11-25

Review 6.  Role of Eryptosis in Hemorrhagic Stroke.

Authors:  Mei Fang; Fan Xia; Yuqi Chen; Yuke Shen; Lu Ma; Chao You; Chuanyuan Tao; Xin Hu
Journal:  Front Mol Neurosci       Date:  2022-07-28       Impact factor: 6.261

7.  Interactions between Biliverdin, Oxidative Damage, and Spleen Morphology after Simulated Aggressive Encounters in Veiled Chameleons.

Authors:  Michael W Butler; Russell A Ligon
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

8.  Carmustine-induced phosphatidylserine translocation in the erythrocyte membrane.

Authors:  Kashif Jilani; Florian Lang
Journal:  Toxins (Basel)       Date:  2013-04-19       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.